Vitamin D binding protein isoforms and apolipoprotein E in cerebrospinal fluid as prognostic biomarkers of multiple sclerosis

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Perga, Simona ^a,c   Albo, Alessandra Giuliano ^b   Lis, Katarzyna ^b   Minari, Nicoletta ^b   Falvo, Sara ^b   Marnetto, Fabiana ^a,c   Caldano, Marzia ^a,c   Reviglione, Raffaella ^b   Berchialla, Paola ^c   Capobianco, Marco A ^a   Malentacchi, Maria ^a   Corpillo, Davide ^b   Bertolotto, Antonio ^a,c  

^a SAN LUIGI GONZAGA UNIVERSITY HOSPITAL   (Italy)

^b Bioindustry Park Silvano Fumero   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BIOLOGICAL MARKER; ISOPROTEIN; PROTEOME; VITAMIN D BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LUMBAR PUNCTURE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; PATIENT MONITORING; PROGNOSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROCESSING; TWO DIMENSIONAL ELECTROPHORESIS; WESTERN BLOTTING; CLASSIFICATION; CLUSTER ANALYSIS; METABOLISM; MIDDLE AGED; PROCEDURES; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; YOUNG ADULT;

ADOLESCENT; ADULT; APOLIPOPROTEINS E; BIOMARKERS; BLOTTING, WESTERN; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; MASS SPECTROMETRY; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; PROTEIN ISOFORMS; PROTEOME; PROTEOMICS; VITAMIN D-BINDING PROTEIN; YOUNG ADULT;

EID: 84934984960     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0129291     Document Type: Article

References (42)

1. Comabella M, Montalban X (2014) Body fluid biomarkers in multiple sclerosis. Lancet Neurol 13: 113-26. doi: 10.1016/S1474-4422(13)70233-3 PMID: 24331797
2. Craft GE, Chen A, Nairn AC (2013) Recent advances in quantitative neuroproteomics. Methods 61: 186-218. doi: 10.1016/j.ymeth.2013.04.008 PMID: 23623823
3. Giovannoni G (2014) Cerebrospinal fluid analysis. Handb Clin Neurol 122: 681-702. doi: 10.1016/B978-0-444-52001-2.00029-7 PMID: 24507540
4. Teunissen CE, Petzold A, Bennett JL, Berven FS, Brundin L, Comabella M, et al. (2009) A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 73: 1914-1922. doi: 10.1212/WNL.0b013e3181c47cc2 PMID: 19949037
5. Teunissen C, Menge T, Altintas A, Alvarez-Cermeño JC, Bertolotto A, Berven FS, et al. (2013) Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 19: 1802-9. doi: 10.1177/1352458513488232 PMID: 23695446
6. Qin Z, Qin Y, Liu S (2008) Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cellular and Molecular Neurobiology 29: 203-210. doi: 10.1007/s10571-008-9312-z PMID: 18807170
7. Lehmensiek V, Süssmuth SD, Tauscher G, Brettschneider J, Felk S, Gillardon F, et al. (2007) Cerebrospinal fluid proteome profile in multiple sclerosis. Mult Scler 13: 840-849. PMID: 17881397
8. Stoop MP, Singh V, Dekker LJ, Titulaer MK, Stingl C, Burgers PC, et al. (2010) Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis. PlosOne 5: 1-8.
9. Chiasserini D, van Weering JR, Piersma SR, Pham TV, Malekzadeh A, Teunissen CE, et al. (2014) Proteomic analysis of cerebrospinal fluid extracellular vesicles: a comprehensive dataset. J Proteomics 106: 191-20. doi: 10.1016/j.jprot.2014.04.028 PMID: 24769233
10. Tumani H, Lehmensiek D, Rau D, Guttmann I, Tauscher G, Mogel H, et al. (2009) CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis. Neuroscience Letters 452: 214-21. doi: 10.1016/j.neulet.2009.01.057 PMID: 19383442
11. Liguori M, Qualtieri A, Tortorella C, Direnzo V, Bagalà, Mastrapasqua M, et al. (2014) Proteomic profiling in multiple sclerosis clinical courses reveals potential biomarkers of neurodegeneration. PLoS One 6: 9(8).
12. Ottervald J, Frazen B. Nilsson K, Andersson LI, Khademi M, Eriksson B, et al. (2010) Multiple sclerosis: identification and clinical evaluation of novel CSF biomarkers. Journal of Proteomics 73: 1117-1132. doi: 10.1016/j.jprot.2010.01.004 PMID: 20093204
13. Teunissen CE, Koel-Simmelink MJ, Pham TV, Knol JC, Khalil M, Trentini A, et al. (2011) Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry. Mult Scler 17: 838-50. doi: 10.1177/1352458511399614 PMID: 21505015
14. Bertolotto A, Malentacchi M, Capobianco M, Di Sapio A, Malucchi S, Motuzova Y, et al. (2015) Postdural puncture headache is markedly reduced when 25 Sprotte needles are used. Cephalalgia Epub ahead of print.
15. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 58:840-6. PMID: 16283615
16. Robotti A, Natale M, Giuliano Albo A, Lis K, Perga S, Marnetto F, et al. (2010) Acute-phase proteins investigation based on lectins affinity capture prior to 2-DE separation: application to serum from multiple sclerosis patients. Electrophoresis 17: 2882-2896. doi: 10.1002/elps.201000171 PMID: 20715125
17. Agrawal GK, Thelen JJ (2005) Development of a simplified, economical polyacrylamide gel staining protocol for phosphoproteins. Proteomics 5: 4684-4688. PMID: 16267815
18. Mila S, Giuliano Albo A, Corpillo D, Giraudo S, Zibetti M, Bucci EM, et al. (2009) Lymphocyte proteomics of Parkinson's disease patients reveals cytoskeletal protein dysregulation and oxidative stress. Biomarkers Med 3: 117-28. doi: 10.2217/bmm.09.4 PMID: 20477505
19. Kurtzke J (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444-52. PMID: 6685237
20. Hühmer AF, Biringer RG, Amato H, Fonteh AN, Harrington MG (2006) Protein analysis in human cerebrospinal fluid: physiological aspects, current progress and further challenges. Disease markers 22: 3-26. PMID: 16410649
21. Eriksson B, Franzen B, Ottervald J (2008) Method for diagnosing Multiple Sclerosis. US2008171394.
22. Kroksveen AC, Opsahl JA, Aye TT, Ulvik RJ, Berven FS (2011) Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics. J Proteomics 74: 371-88. doi: 10.1016/j.jprot.2010.11.010 PMID: 21111852
23. Axelsson M, Mattsson N, Malmeström C, Zetterberg H, Lycke J (2013) The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis. J Neuroimmunol 264: 100-5. doi: 10.1016/j.jneuroim.2013.09.003 PMID: 24125567
24. Smolders J, Peelen E, Thewissen M, Menheere P, Damoiseaux J, Hupperts R. (2013) Circulating vitamin D binding protein levels are not associated with relapses or with vitamin D status in multiple sclerosis. Mult Scler 20(4): 433-7. doi: 10.1177/1352458513500552 PMID: 23959712
25. Lanzillo R, Quarantelli M, Bonavita S, Ventrella G, Lus G, Vacca G, et al. (2012) Natalizumab vs interferon beta 1a in relapsing-remitting multiple sclerosis: a head-to-head retrospective study. Acta Neurol Scand 126: 306-14. doi: 10.1111/j.1600-0404.2011.01622.x PMID: 22107083
26. Singer B, Ross AP, Tobias K (2012) Oral fingolimod for the treatment of patients with relapsing forms of multiple sclerosis. Int J Clin Pract 65: 887-95.
27. Chun RF (2012) New perspectives on the vitamin D binding protein. Cell Biochem Funct 30: 445-56. doi: 10.1002/cbf.2835 PMID: 22528806
28. Kroksveen AC, Guldbrandsen A, Vedeler C, Myhr KM, Opsahl JA, Berven FS (2012) Cerebrospinal fluid proteome comparison between multiple sclerosis patients and controls. Acta Neurol Scand Suppl 195: 90-6. doi: 10.1111/ane.12029 PMID: 23278663
29. Disanto G, Ramagopalan SV, Para AE, Handunnetthi L (2010) The emerging role of vitamin D binding protein in multiple sclerosis. J Neurol 258: 353-8. doi: 10.1007/s00415-010-5797-8 PMID: 21042807
30. Sawcer S, Hellenthal G, Pirinen M, Spencer CC, Patsopoulos NA, Moutsianas L et al. (2011) Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476: 214-219. doi: 10.1038/nature10251 PMID: 21833088
31. Kulakowska A, Drozdowski W, Sadzynski A, Bucki R, Janmey PA (2009) Gelsolin concentration in cerebrospinal fluid from patients with multiple sclerosis and other neurological disorders. European Journal of Neurology 15: 584-588.
32. Kulakowska A, Ciccarelli NJ, Wen Q, Mroczko B, Drozdowski Szmitkowski M, et al. (2010) Hypogelsolinemia, a disorder of the extracellular actin scavenger system, in patients with multiple sclerosis. BMC Neurology 10: 107. doi: 10.1186/1471-2377-10-107 PMID: 21040581
33. Yang M, Qin Z, Zhu Y, Li Y, Qin Y, Jing Y, et al. (2013) Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression. Mol Neurobiol 47: 946-56. doi: 10.1007/s12035-012-8387-1 PMID: 23339019
34. Rehder DS, Nelson RW, Borges CR (2009) Glycosylation status of vitamin D binding protein in cancer patients. Protein Sci. 18: 2036-42. doi: 10.1002/pro.214 PMID: 19642159
35. Ravnsborg T, Olsen DT, Hammerich Thysen A, Christiansen M, Houen G, Højrup P (2010) The glycosylation and characterization of the candidate Gc macrophage activating factor. Biochimica and Biophysica Acta 1804: 909-917. doi: 10.1016/j.bbapap.2009.12.022 PMID: 20079467
36. Chun RF, Peercy BE, Orwoll ES, Nielson CM, Adams JS, Hewison M (2013) Vitamin D and DBP: the free hormone hypothesis revisited. J Steroid Biochem Mol Biol 144: 132-7. doi: 10.1016/j.jsbmb.2013.09.012 PMID: 24095930
37. Gibson DS, Newell K, Evans AN, Finnegan S, Manning G, Scaife C, et al. (2012) Vitamin D binding protein isoforms as candidate predictors of disease extension in childhood arthritis. J Proteomics 75: 5479-92. doi: 10.1016/j.jprot.2012.06.024 PMID: 22771520
38. Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M (2012) Effects of vitamin D-binding protein-derived macrophage-activating factor on human breast cancer cells. Anticancer Res 32: 45-52. PMID: 22213287
39. Lauridsen AL, Vestergaard P, Hermann AP, Brot C, Heickendorff L, Mosekilde L, et al. (2005) Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int 77: 15-22. PMID: 15868280
40. Lauridsen AL, Vestergaard P, Nexo E (2001) Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem 47: 753-6. PMID: 11274031
41. Moy KA, Mondul AM, Zhang H, Weinstein SJ, Wheeler W, Chung CC, et al. (2014) Genome-wide association study of circulating vitamin D-binding protein. Am J Clin Nutr 99: 1424-1431. doi: 10.3945/ajcn.113.080309 PMID: 24740207
42. Tamam Y, Tasdemir N, Yalman M, Tamam B (2011) Association of apolipoprotein E genotypes with prognosis in multiple sclerosis. Eur Rev Med Pharmacol Sci 15: 1122-30. PMID: 22165672